SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+20.28%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$302M
AUM Growth
+$302M
(+19%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
7.88%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
62
New
24
Increased
12
Reduced
14
Closed
11
Top Buys
| 1 |
Quest Diagnostics
DGX
|
$14.2M |
| 2 |
Labcorp
LH
|
$9.97M |
| 3 |
Hologic
HOLX
|
$5.7M |
| 4 |
Medtronic
MDT
|
$5.5M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
$5.23M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$16.5M |
| 2 |
UnitedHealth
UNH
|
$10.6M |
| 3 |
Encompass Health
EHC
|
$7.73M |
| 4 |
Universal Health Services
UHS
|
$6.54M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$6.02M |
Sector Composition
| 1 | Healthcare | 95.1% |
| 2 | Energy | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Quest Diagnostics
DGX
$20.3B
| $14.2M | 4.72% | +125,000 | New | +$14.2M |
|
2
Humana
HUM
$36.5B
| $11.9M | 3.95% | 67,500 +17,500 | +35% | +$3.09M |
|
3
McKesson
MCK
$85.4B
| $11.8M | 3.9% | 32,500 | – | – |
|
4
Smith & Nephew
SNN
$16.3B
| $11.6M | 3.86% | 120,000 -15,187 | -11% | -$1.47M |
|
|
5
Labcorp
LH
$23.1B
| $9.97M | 3.3% | +60,000 | New | +$9.97M |
|
6
Stryker
SYK
$150B
| $9.85M | 3.26% | 60,000 +10,000 | +20% | +$1.64M |
|
7
Cencora
COR
$56.5B
| $9.69M | 3.21% | 25,000 -15,000 | -38% | -$5.82M |
|
8
HCA Healthcare
HCA
$94.5B
| $9.6M | 3.18% | 105,000 +10,000 | +11% | +$914K |
|
|
HRC
9
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.55M | 3.16% | 80,000 +40,000 | +100% | +$4.77M |
|
10
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.36M | 3.1% | 15,000 +5,000 | +50% | +$3.12M |
|
11
Incyte
INCY
$16.5B
| $9.29M | 3.08% | 100,000 -15,000 | -13% | -$1.39M |
|
12
AstraZeneca
AZN
$248B
| $9.21M | 3.05% | 60,000 -15,000 | -20% | -$2.3M |
|
13
Centene
CNC
$14.3B
| $8.87M | 2.94% | 170,000 -5,000 | -3% | -$261K |
|
14
Select Medical
SEM
$1.61B
| $8.43M | 2.79% | 115,000 +35,000 | +44% | +$2.57M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $8.13M | 2.69% | 220,000 -15,000 | -6% | -$554K |
|
16
Danaher
DHR
$147B
| $8.06M | 2.67% | 80,000 -35,000 | -30% | -$3.53M |
|
17
Novo Nordisk
NVO
$251B
| $7.37M | 2.44% | 210,000 -40,000 | -16% | -$1.4M |
|
18
Intuitive Surgical
ISRG
$170B
| $7.24M | 2.4% | 400,000 -85,523 | -18% | -$1.55M |
|
19
Cardinal Health
CAH
$35.5B
| $6.46M | 2.14% | 75,000 -15,000 | -17% | -$1.29M |
|
20
Cigna
CI
$80.3B
| $6.31M | 2.09% | 35,000 -10,000 | -22% | -$1.8M |
|
21
AbbVie
ABBV
$372B
| $5.87M | 1.94% | 13,000 +3,000 | +30% | +$1.35M |
|
|
22
Hologic
HOLX
$14.9B
| $5.7M | 1.89% | +100,000 | New | +$5.7M |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $5.63M | 1.87% | 30,000 +5,000 | +20% | +$938K |
|
|
24
Medtronic
MDT
$119B
| $5.5M | 1.82% | +60,000 | New | +$5.5M |
|
25
Merck
MRK
$210B
| $5.26M | 1.74% | 85,000 +5,000 | +6% | +$310K |
|